{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:47:45Z","timestamp":1789678065274,"version":"4.0.1"},"reference-count":288,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["21PJ083"],"award-info":[{"award-number":["21PJ083"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200810"],"award-info":[{"award-number":["82200810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Health Commission of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0331"],"award-info":[{"award-number":["2022YFS0331"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1526"],"award-info":[{"award-number":["2023NSFSC1526"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.diabres.2025.112235","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T19:29:23Z","timestamp":1746473363000},"page":"112235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions"],"prefix":"10.1016","volume":"224","author":[{"given":"Haoyu","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Human reproduction"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0015","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndromedagger","volume":"38","author":"Teede","year":"2023","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b0020","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ejendo\/lvae125","article-title":"Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis","volume":"191","author":"Neven","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"25","key":"10.1016\/j.diabres.2025.112235_b0035","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1210\/endrev\/bnae002","article-title":"Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome","volume":"45","author":"Chen","year":"2024","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0050","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1210\/jc.2012-2109","article-title":"Persistence pays off for PCOS gene prospectors","volume":"97","author":"Strauss","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tem.2014.12.004","article-title":"Functional genomics of PCOS: from GWAS to molecular mechanisms","volume":"26","author":"McAllister","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0034-1371087","article-title":"Intrauterine environment and polycystic ovary syndrome","volume":"32","author":"Dumesic","year":"2014","journal-title":"Semin Reprod Med"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0065","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/humrep\/des027","article-title":"Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood","volume":"27","author":"Davies","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.diabres.2025.112235_b0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.reprotox.2018.09.006","article-title":"Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome","volume":"82","author":"Konieczna","year":"2018","journal-title":"Reprod Toxicol"},{"issue":"48","key":"10.1016\/j.diabres.2025.112235_b0075","doi-asserted-by":"crossref","first-page":"67925","DOI":"10.1007\/s11356-021-16489-4","article-title":"Implications of environmental toxicants on ovarian follicles: how it can adversely affect the female fertility?","volume":"28","author":"Priya","year":"2021","journal-title":"Environ Sci Pollut Res Int"},{"issue":"23","key":"10.1016\/j.diabres.2025.112235_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16234816","article-title":"Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort Analysis","volume":"16","author":"Lin","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12902-020-0497-6","article-title":"Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0090","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/jc.2018-01143","article-title":"Saturated Fat Ingestion Promotes Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Polycystic Ovary Syndrome","volume":"104","author":"Gonzalez","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112235_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116940","article-title":"Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome","volume":"236","author":"Wang","year":"2019","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0100","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0105","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoae013","article-title":"Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS","volume":"2024","author":"Li","year":"2024","journal-title":"Hum Reprod Open"},{"issue":"13","key":"10.1016\/j.diabres.2025.112235_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310611","article-title":"3rd, Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome","volume":"24","author":"Harris","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.diabres.2025.112235_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197054","article-title":"In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond","volume":"21","author":"Wawrzkiewicz-Jalowiecka","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"36","key":"10.1016\/j.diabres.2025.112235_b0120","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.2174\/1381612822666160726103133","article-title":"Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines","volume":"22","author":"Dimitriadis","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-003-1324-0","article-title":"Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots","volume":"47","author":"Dicker","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112235_b0130","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-18-0573","article-title":"Emerging role of testosterone in pancreatic beta-cell function and insulin secretion","author":"Xu","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/j.diabres.2025.112235_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"issue":"10302","key":"10.1016\/j.diabres.2025.112235_b0140","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"issue":"10225","key":"10.1016\/j.diabres.2025.112235_b0145","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"The lancet"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0150","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.0000000000000170","article-title":"Genome-Wide Association Study of CKD Progression","volume":"34","author":"Robinson-Cohen","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0155","doi-asserted-by":"crossref","first-page":"9317","DOI":"10.1038\/s41467-024-53516-7","article-title":"Discovery and prioritization of genetic determinants of kidney function in 297,355 individuals from Taiwan and Japan","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.kint.2021.09.005","article-title":"A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function","volume":"101","author":"Heerspink","year":"2022","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"Meng","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41581-023-00775-0","article-title":"Oxidative stress and the role of redox signalling in chronic kidney disease","volume":"20","author":"Kishi","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0180","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41581-022-00621-9","article-title":"Targeting innate immunity-driven inflammation in CKD and cardiovascular disease","volume":"18","author":"Speer","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121584","article-title":"The Interplay between Immune and Metabolic Pathways in Kidney Disease","volume":"12","author":"Qu","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1053\/j.ackd.2017.08.003","article-title":"Epidemiology of Acid-Base Derangements in CKD","volume":"24","author":"Chen","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0200","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0205","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cen.14284","article-title":"The risk of chronic kidney disease among women with polycystic ovary syndrome: A long-term population-based cohort study","volume":"93","author":"Behboudi-Gandevani","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.diabres.2025.112235_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1120119","article-title":"Causal relationship between polycystic ovary syndrome and chronic kidney disease: A Mendelian randomization study","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"20","key":"10.1016\/j.diabres.2025.112235_b0215","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13461","article-title":"Consequences of advanced aging on renal function in chronic hyperandrogenemic female rat model: implications for aging women with polycystic ovary syndrome","volume":"5","author":"Patil","year":"2017","journal-title":"Physiol Rep"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0220","first-page":"176","article-title":"Association of Glomerular Filtration Rate with Inflammation in Polycystic Ovary Syndrome","volume":"9","author":"Gozukara","year":"2015","journal-title":"Int J Fertil Steril"},{"issue":"2Part B","key":"10.1016\/j.diabres.2025.112235_b0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cjco.2023.12.010","article-title":"Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort","volume":"6","author":"Vine","year":"2024","journal-title":"CJC Open"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073789","article-title":"Chronic Low Grade Inflammation in Pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2025.112235_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156588","article-title":"Cytokine and chemokine profiles in women with endometriosis, polycystic ovary syndrome, and unexplained infertility","volume":"178","author":"Omidvar-Mehrabadi","year":"2024","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0240","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update","volume":"303","author":"Abraham Gnanadass","year":"2021","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","article-title":"Proinflammatory cytokines","volume":"118","author":"Dinarello","year":"2000","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0250","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biocel.2011.03.001","article-title":"Cytokines: signalling molecules controlling ovarian functions","volume":"43","author":"Sirotkin","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.diabres.2025.112235_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1324429","article-title":"Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging","volume":"14","author":"Orisaka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0260","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41401-023-01128-0","article-title":"Serum granulosa cell-derived TNF-alpha promotes inflammation and apoptosis of renal tubular cells and PCOS-related kidney injury through NF-kappaB signaling","volume":"44","author":"Ye","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.diabres.2025.112235_b0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of Renal Fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu Rev Physiol"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0270","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/thno.81406","article-title":"The STAT1\/HMGB1\/NF-kappaB pathway in chronic inflammation and kidney injury after cisplatin exposure","volume":"13","author":"Fu","year":"2023","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-kappaB by TNF family cytokines","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.diabres.2025.112235_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106179","article-title":"Acetate: A therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome","volume":"225","author":"Olaniyi","year":"2023","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0285","first-page":"3696","article-title":"SDF\u20111\/CXCR4 induces epithelial\u2011mesenchymal transition through activation of the Wnt\/beta\u2011catenin signaling pathway in rat chronic allograft nephropathy","volume":"19","author":"Tang","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.diabres.2025.112235_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101809","article-title":"CXCL12\/CXCR4: An amazing challenge and opportunity in the fight against fibrosis","volume":"83","author":"Wu","year":"2023","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40360-023-00692-9","article-title":"Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1","volume":"24","author":"Bashir","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"issue":"15","key":"10.1016\/j.diabres.2025.112235_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/cells12152002","article-title":"Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients","volume":"12","author":"Butler","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.diabres.2025.112235_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.935750","article-title":"Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D","volume":"13","author":"Moin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094899","article-title":"A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome","volume":"25","author":"Butler","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2025.112235_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1326344","article-title":"Causal association of immune cells and polycystic ovarian syndrome: a Mendelian randomization study","volume":"14","author":"Aru","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2025.112235_b0320","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2019.01.048","article-title":"Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome","volume":"220","author":"Moulana","year":"2019","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0325","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxp021","article-title":"Th17 cells: from precursors to players in inflammation and infection","volume":"21","author":"Awasthi","year":"2009","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030730","article-title":"The Balance of Th17 versus Treg Cells in Autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2025.112235_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106265","article-title":"Ulinastatin ameliorates acute kidney injury induced by crush syndrome inflammation by modulating Th17\/Treg cells","volume":"81","author":"Yang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.diabres.2025.112235_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155452","article-title":"Altered Th17\/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy","volume":"141","author":"Motavalli","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.diabres.2025.112235_b0345","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8813558","article-title":"The Function and Role of the Th17\/Treg Cell Balance in Inflammatory Bowel Disease","volume":"2020","author":"Yan","year":"2020","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/met.2006.4.122","article-title":"Association between Circulating Tumor Necrosis Factor-Alpha, Interleukin-6, and Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome","volume":"4","author":"Tarkun","year":"2006","journal-title":"Metab Syndr Relat Disord"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0355","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/09513590.2018.1428301","article-title":"Association between Th1\/Th2 immune imbalance and obesity in women with or without polycystic ovary syndrome","volume":"34","author":"Gong","year":"2018","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0360","first-page":"175","article-title":"T Helper Cells Profile and CD4+CD25+Foxp3+Regulatory T Cells in Polycystic Ovary Syndrome","volume":"15","author":"Nasri","year":"2018","journal-title":"Iran J Immunol"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0365","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081144","article-title":"Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases","volume":"11","author":"Aranda-Rivera","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083923","article-title":"Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome","volume":"22","author":"Dabravolski","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0380","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12958-023-01159-6","article-title":"A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS","volume":"21","author":"Awonuga","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.diabres.2025.112235_b0385","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4579831","article-title":"Role of Oxidative Stress in Obese and Nonobese PCOS Patients","volume":"2022","author":"Uckan","year":"2022","journal-title":"Int J Clin Pract"},{"issue":"18","key":"10.1016\/j.diabres.2025.112235_b0390","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814126","article-title":"Polycystic Ovary Syndrome and Oxidative Stress-From Bench to Bedside","volume":"24","author":"Zeber-Lubecka","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-019-0509-4","article-title":"Polycystic ovary syndrome and mitochondrial dysfunction","volume":"17","author":"Zhang","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011302","article-title":"Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice","volume":"5","author":"Liu","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0405","doi-asserted-by":"crossref","first-page":"E1298","DOI":"10.1210\/jc.2011-0278","article-title":"Intact primary mitochondrial function in myotubes established from women with PCOS","volume":"96","author":"Eriksen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0410","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.metabol.2011.04.010","article-title":"Mitochondrial DNA copy number in peripheral blood in polycystic ovary syndrome","volume":"60","author":"Lee","year":"2011","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b0415","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-11-0419","article-title":"Skeletal muscle mitochondrial function in polycystic ovarian syndrome","volume":"165","author":"Rabol","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2025.112235_b0420","article-title":"Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome","volume":"10","author":"Gao","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0425","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40738-020-00094-z","article-title":"Evaluation of oocyte quality in Polycystic ovary syndrome patients undergoing ART cycles","volume":"7","author":"Nikbakht","year":"2021","journal-title":"Fertil Res Pract"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0430","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0435","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5468\/ogs.2019.62.5.335","article-title":"Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital","volume":"62","author":"Enechukwu","year":"2019","journal-title":"Obstet Gynecol Sci"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0440","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","article-title":"Oxidative stress in chronic kidney disease","volume":"34","author":"Daenen","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0445","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/ars.2020.8106","article-title":"Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension","volume":"34","author":"Yang","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"48","key":"10.1016\/j.diabres.2025.112235_b0450","doi-asserted-by":"crossref","first-page":"37503","DOI":"10.1074\/jbc.M110.136796","article-title":"AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes","volume":"285","author":"Eid","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0455","first-page":"187","article-title":"Association of Oxidative Stress with Kidney Injury in a Hyperandrogenemic Female Rat Model","volume":"48","author":"Forghani","year":"2023","journal-title":"Iran J Med Sci"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0460","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/acs.jproteome.5b00307","article-title":"NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome","volume":"14","author":"Selen","year":"2015","journal-title":"J Proteome Res"},{"issue":"11","key":"10.1016\/j.diabres.2025.112235_b0465","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1016\/j.sjbs.2021.06.066","article-title":"Chamomile flower extract ameliorates biochemical and histological kidney dysfunction associated with polycystic ovary syndrome","volume":"28","author":"Alahmadi","year":"2021","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0470","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2357737","article-title":"The latest reports and treatment methods on polycystic ovary syndrome","volume":"56","author":"Stanczak","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.diabres.2025.112235_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.670076","article-title":"Coordinated Contribution of NADPH Oxidase- and Mitochondria-Derived Reactive Oxygen Species in Metabolic Syndrome and Its Implication in Renal Dysfunction","volume":"12","author":"Lee","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabres.2025.112235_b0480","article-title":"Metabolic Syndrome-Related Kidney Injury: A Review and Update","volume":"13","author":"Lin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0485","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.fertnstert.2009.01.056","article-title":"Serologic markers of autoimmunity in women with polycystic ovary syndrome","volume":"93","author":"Hefler-Frischmuth","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0490","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13224-013-0451-x","article-title":"Serum Levels of Anti-histone and Anti-double-Strand DNA Antibodies Before and After Laparoscopic Ovarian Drilling in Women with Polycystic Ovarian Syndrome","volume":"64","author":"Samsami","year":"2014","journal-title":"J Obstet Gynaecol India"},{"issue":"2 Suppl","key":"10.1016\/j.diabres.2025.112235_b0495","first-page":"187","article-title":"Anti-Nuclear Antibodies in Patients with Polycystic Ovary Syndrome before and after Laparoscopic Electrocauterization","volume":"38","author":"Samsami Dehaghani","year":"2013","journal-title":"Iran J Med Sci"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0500","first-page":"21","article-title":"Evaluation of ANA-related serologic autoantibodies in polycystic ovary syndrome. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Immunology","volume":"14","author":"Hamedi","year":"2014","journal-title":"Endocrine and Metabolic Agents)"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0505","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.17954","article-title":"Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: a case-control study from syria","volume":"12","author":"Al-Saab","year":"2014","journal-title":"Int J Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0510","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5507\/bp.2014.062","article-title":"The prevalence of non organ specific and thyroid autoimmunity in patients with polycystic ovary syndrome","volume":"159","author":"Petrikova","year":"2015","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.diabres.2025.112235_b0515","article-title":"Correlation between Hashimoto's thyroiditis and polycystic ovary syndrome: A systematic review and meta-analysis","volume":"13","author":"Hu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2025.112235_b0520","article-title":"Dysregulation of immune response in PCOS organ system","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2025.112235_b0525","article-title":"Polycystic Ovary Syndrome May Be an Autoimmune Disorder","volume":"2016","author":"Mobeen","year":"2016","journal-title":"Scientifica (Cairo)"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0530","article-title":"An Atypical Case of Polycystic Ovarian Syndrome and Possible Newly Diagnosed Systemic Lupus Erythematosus Complicated With a Cerebrovascular Accident in a Young Female: A Case Report","volume":"16","author":"Arrey Agbor","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.diabres.2025.112235_b0535","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T Cell Metabolism: A New Perspective on Th17\/Treg Cell Imbalance in Systemic Lupus Erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2025.112235_b0540","doi-asserted-by":"crossref","first-page":"i65","DOI":"10.1136\/ard.2009.117135","article-title":"Treg and lupus","volume":"69","author":"Bonelli","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0545","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00438-023-02071-9","article-title":"Assessing the causal relationship between immune traits and systemic lupus erythematosus by bi-directional Mendelian randomization analysis","volume":"298","author":"Gu","year":"2023","journal-title":"Mol Genet Genomics"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0550","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on Lupus Nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0555","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cen.14710","article-title":"Approach to androgen excess in women: Clinical and biochemical insights","volume":"97","author":"Cussen","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.diabres.2025.112235_b0560","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.08.016","article-title":"Intracrine androgen biosynthesis, metabolism and action revisited","volume":"465","author":"Schiffer","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"4850","key":"10.1016\/j.diabres.2025.112235_b0565","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1126\/science.3353727","article-title":"Cloning of human androgen receptor complementary DNA and localization to the X chromosome","volume":"240","author":"Lubahn","year":"1988","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113090","article-title":"Bromodomain-containing protein 4 activates androgen receptor transcription and promotes ovarian fibrosis in PCOS","volume":"42","author":"Wang","year":"2023","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0575","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s43032-019-00137-x","article-title":"Luteinizing Hormone Action in Human Oocyte Maturation and Quality: Signaling Pathways, Regulation, and Clinical Impact","volume":"27","author":"Arroyo","year":"2020","journal-title":"Reprod Sci"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0580","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0585","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.diabres.2025.112235_b0590","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0595","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/en.2003-0329","article-title":"Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1\/2 in human ovarian theca cells","volume":"145","author":"Munir","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabres.2025.112235_b0600","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.anireprosci.2018.01.014","article-title":"Effect of luteinizing hormone on goat theca cell apoptosis and steroidogenesis through activation of the PI3K\/AKT pathway","volume":"190","author":"Wang","year":"2018","journal-title":"Anim Reprod Sci"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0605","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/jc.2009-0139","article-title":"KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women","volume":"94","author":"Du","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0610","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0615","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12958-017-0231-z","article-title":"Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review","volume":"15","author":"Paixao","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0620","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jc.2014-2569","article-title":"Adrenal androgen excess and body mass index in polycystic ovary syndrome","volume":"100","author":"Moran","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112235_b0625","article-title":"Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome","volume":"2018","author":"Zhang","year":"2018","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0630","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2018.04.078","article-title":"Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS","volume":"503","author":"Mondal","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071694","article-title":"Visualising androgen receptor activity in male and female mice","volume":"8","author":"Dart","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2025.112235_b0640","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2017.11.011","article-title":"Sex steroids and the kidney: role in renal calcium and phosphate handling","volume":"465","author":"Khalil","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0645","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.5455\/OVJ.2023.v13.i8.6","article-title":"Evaluation of renal disturbance in animal models of polycystic ovary syndrome","volume":"13","author":"Oktanella","year":"2023","journal-title":"Open Vet J"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b0650","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1523-1755.2004.00497.x","article-title":"Testosterone promotes apoptotic damage in human renal tubular cells","volume":"65","author":"Verzola","year":"2004","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0655","doi-asserted-by":"crossref","first-page":"E435","DOI":"10.1152\/ajpendo.00704.2006","article-title":"Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling","volume":"294","author":"Metcalfe","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0660","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12967-019-1821-7","article-title":"Testosterone induces renal tubular epithelial cell death through the HIF-1alpha\/BNIP3 pathway","volume":"17","author":"Peng","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.diabres.2025.112235_b0665","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1000650","article-title":"Associations of endogenous androgens and sex hormone-binding globulin with kidney function and chronic kidney disease","volume":"13","author":"Lau","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"16","key":"10.1016\/j.diabres.2025.112235_b0670","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14219","article-title":"Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury","volume":"7","author":"Song","year":"2019","journal-title":"Physiol Rep"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0675","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1210\/en.2015-1617","article-title":"Cardiometabolic Effects of Chronic Hyperandrogenemia in a New Model of Postmenopausal Polycystic Ovary Syndrome","volume":"157","author":"Dalmasso","year":"2016","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0680","doi-asserted-by":"crossref","first-page":"R708","DOI":"10.1152\/ajpregu.00411.2014","article-title":"Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats","volume":"308","author":"Maranon","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0685","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/HJH.0b013e328344db3a","article-title":"Renal denervation: a potential new treatment modality for polycystic ovary syndrome?","volume":"29","author":"Schlaich","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.diabres.2025.112235_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119456","article-title":"The effect of \u03b3-linolenic acid on Polycystic Ovary Syndrome associated Focal Segmental Glomerulosclerosis via TGF-\u03b2 pathway","volume":"276","author":"Prabhu","year":"2021","journal-title":"Life Sciences"},{"key":"10.1016\/j.diabres.2025.112235_b0695","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cca.2020.07.032","article-title":"Role of TGF-beta signalling in PCOS associated focal segmental glomerulosclerosis","volume":"510","author":"Bhati","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b0700","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/01913123.2011.584657","article-title":"Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis","volume":"35","author":"Darouich","year":"2011","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.diabres.2025.112235_b0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0710","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/bies.20151","article-title":"Insulin and its receptor: structure, function and evolution","volume":"26","author":"De Meyts","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.diabres.2025.112235_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101255","article-title":"Understanding insulin and its receptor from their three-dimensional structures","volume":"52","author":"Lawrence","year":"2021","journal-title":"Mol Metab"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0720","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1083\/jcb.201802095","article-title":"The cell biology of systemic insulin function","volume":"217","author":"Tokarz","year":"2018","journal-title":"J Cell Biol"},{"key":"10.1016\/j.diabres.2025.112235_b0725","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-biochem-052521-033250","article-title":"The Activation Mechanism of the Insulin Receptor: A Structural Perspective","volume":"92","author":"Choi","year":"2023","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0730","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1210\/jc.2018-01771","article-title":"Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean With Polycystic Ovary Syndrome","volume":"104","author":"Hansen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0735","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/db07-0706","article-title":"Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment","volume":"57","author":"Hojlund","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.112235_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118003","article-title":"Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K\/AkT\/mTOR and TNF-alpha modulations","volume":"256","author":"Abuelezz","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.diabres.2025.112235_b0745","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1091147","article-title":"Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.diabres.2025.112235_b0750","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1210\/jc.2019-00167","article-title":"Molecular Mechanisms of Insulin Resistance in Polycystic Ovary Syndrome: Unraveling the Conundrum in Skeletal Muscle?","volume":"104","author":"Stepto","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112235_b0755","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0760","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26072101","article-title":"beta-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKbeta\/NF-kappaB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats","volume":"26","author":"Jayaraman","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0765","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084110","article-title":"Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism","volume":"23","author":"Armanini","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0770","doi-asserted-by":"crossref","first-page":"C420","DOI":"10.1152\/ajpcell.00141.2019","article-title":"Oxidative stress pathways in pancreatic beta-cells and insulin-sensitive cells and tissues: importance to cell metabolism, function, and dysfunction","volume":"317","author":"Newsholme","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0775","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1210\/jc.2018-00935","article-title":"Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome","volume":"103","author":"Nilsson","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.diabres.2025.112235_b0780","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218191","article-title":"Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0785","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40618-018-0949-2","article-title":"Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome","volume":"42","author":"Mu","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0790","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09513590.2020.1787377","article-title":"Indicator of early kidney injury in adolescents with polycystic ovary syndrome: Can urine NGAL level be?","volume":"37","author":"Karaman","year":"2021","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0795","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12882-019-1220-6","article-title":"Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study","volume":"20","author":"Schrauben","year":"2019","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0800","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.ASN.0000046029.53933.09","article-title":"Insulin resistance and risk of chronic kidney disease in nondiabetic US adults","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0805","article-title":"Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0810","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2410396","article-title":"Sirt6 ameliorates high glucose-induced podocyte cytoskeleton remodeling via the PI3K\/AKT signaling pathway","volume":"46","author":"Zhang","year":"2024","journal-title":"Ren Fail"},{"key":"10.1016\/j.diabres.2025.112235_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108541","article-title":"Regulation of podocytes function by AMP-activated protein kinase","volume":"692","author":"Rogacka","year":"2020","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0820","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41419-018-0324-4","article-title":"Cinacalcet-mediated activation of the CaMKKbeta-LKB1-AMPK pathway attenuates diabetic nephropathy in db\/db mice by modulation of apoptosis and autophagy","volume":"9","author":"Lim","year":"2018","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b0825","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","article-title":"Insulin signaling to the glomerular podocyte is critical for normal kidney function","volume":"12","author":"Welsh","year":"2010","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.diabres.2025.112235_b0830","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00125-017-4394-0","article-title":"Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor","volume":"60","author":"Lay","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0835","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/08860220802134532","article-title":"Effect of genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet","volume":"30","author":"Palanisamy","year":"2008","journal-title":"Ren Fail"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0840","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1462-8902.2004.00332.x","article-title":"Influence of alpha-lipoic acid on lipid peroxidation and antioxidant defence system in blood of insulin-resistant rats","volume":"6","author":"Thirunavukkarasu","year":"2004","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0845","doi-asserted-by":"crossref","first-page":"c163","DOI":"10.1159\/000115329","article-title":"Glucose metabolism, insulin resistance, and renal pathology in non-diabetic chronic kidney disease","volume":"108","author":"Ikee","year":"2008","journal-title":"Nephron Clin Pract"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0850","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrneph.2016.145","article-title":"The impact of insulin resistance on the kidney and vasculature","volume":"12","author":"Artunc","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242332","article-title":"Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics","volume":"15","author":"Hashimoto","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0860","first-page":"671","article-title":"Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited","volume":"36","author":"da Silva","year":"2020","journal-title":"Can J Cardiol"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b0865","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b0870","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/des191","article-title":"Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS","volume":"27","author":"Zhang","year":"2012","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b0875","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.diabres.2025.112235_b0880","article-title":"The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population","volume":"13","author":"Guo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.diabres.2025.112235_b0885","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0890","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b0895","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/endrev\/bnab037","article-title":"A Modern Approach to Dyslipidemia","volume":"43","author":"Berberich","year":"2022","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0900","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmad015","article-title":"PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis","volume":"29","author":"Millan-de-Meer","year":"2023","journal-title":"Hum Reprod Update"},{"issue":"10","key":"10.1016\/j.diabres.2025.112235_b0905","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0026-0495(87)90130-2","article-title":"The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol","volume":"36","author":"Applebaum-Bowden","year":"1987","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2025.112235_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103760","article-title":"Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita","volume":"75","author":"Thompson","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0915","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/JOE-15-0471","article-title":"Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism","volume":"230","author":"Abruzzese","year":"2016","journal-title":"J Endocrinol"},{"issue":"6865","key":"10.1016\/j.diabres.2025.112235_b0920","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0925","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2025.112235_b0930","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.915424","article-title":"Impact of dyslipidemia on the cumulative pregnancy outcomes after first ovarian stimulation","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0935","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/humrep\/dey356","article-title":"Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome","volume":"34","author":"Ezeh","year":"2019","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0940","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2011.04.007","article-title":"Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance","volume":"22","author":"Choi","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0945","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11883-025-01290-2","article-title":"Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk","volume":"27","author":"Theofilis","year":"2025","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b0950","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.numecd.2021.09.037","article-title":"Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD","volume":"32","author":"Lee","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabres.2025.112235_b0955","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1037618","article-title":"Serum triglycerides level is independently associated with renal outcomes in patients with non-dialysis chronic kidney disease: Results from KNOW-CKD study","volume":"9","author":"Suh","year":"2022","journal-title":"Front Nutr"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0960","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011162","article-title":"Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD","volume":"8","author":"Nam","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.diabres.2025.112235_b0965","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41419-020-03122-4","article-title":"High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction","volume":"11","author":"Sun","year":"2020","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b0970","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1681\/ASN.2016070731","article-title":"High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney","volume":"28","author":"Yamamoto","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100610","article-title":"Dyslipidemia-induced renal fibrosis related to ferroptosis and endoplasmic reticulum stress","volume":"65","author":"Jiang","year":"2024","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b0980","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa125","article-title":"Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study","volume":"105","author":"Zhao","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0985","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/humrep\/dey343","article-title":"Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome","volume":"34","author":"Brower","year":"2019","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b0990","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/GRF.0b013e31802f54c8","article-title":"Obesity and lifestyle management in polycystic ovary syndrome","volume":"50","author":"Hoeger","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.diabres.2025.112235_b0995","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1000","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12902-024-01733-y","article-title":"Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome","volume":"24","author":"Mansour","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1005","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1210\/clinem\/dgab633","article-title":"Causal Associations of Obesity With Chronic Kidney Disease and Arterial Stiffness: A Mendelian Randomization Study","volume":"107","author":"Ye","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112235_b1010","article-title":"Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium","volume":"364","author":"Chang","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b1015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-024-00951-7","article-title":"Obesity and the kidney: mechanistic links and therapeutic advances","volume":"20","author":"Yau","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1020","first-page":"55","article-title":"Hypertension in Polycystic Ovary Syndrome: Novel Insights","volume":"16","author":"Macut","year":"2020","journal-title":"Curr Hypertens Rev"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ddr.22027","article-title":"PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro","volume":"84","author":"Ji","year":"2023","journal-title":"Drug Dev Res"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11695-015-1902-5","article-title":"The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis","volume":"26","author":"Skubleny","year":"2016","journal-title":"Obes Surg"},{"issue":"12","key":"10.1016\/j.diabres.2025.112235_b1035","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.rbmo.2021.05.008","article-title":"Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention","volume":"43","author":"Dietz de Loos","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b1045","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2020030384","article-title":"Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis","volume":"32","author":"Kelly","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1681\/ASN.2021050668","article-title":"Effect of a 3-Year Lifestyle Intervention in Patients with Chronic Kidney Disease: A Randomized Clinical Trial","volume":"33","author":"Beetham","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1060","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1038\/s41467-020-19003-5","article-title":"Defining the impact of dietary macronutrient balance on PCOS traits","volume":"11","author":"Rodriguez Paris","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b1065","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041066","article-title":"Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases","volume":"12","author":"Mirabelli","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13668-023-00451-6","article-title":"The Effect on Inflammation of Adherence to the Mediterranean Diet in Polycystic Ovary Syndrome","volume":"12","author":"Citar Daziroglu","year":"2023","journal-title":"Curr Nutr Rep"},{"issue":"10","key":"10.1016\/j.diabres.2025.112235_b1075","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102278","article-title":"Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS)","volume":"11","author":"Barrea","year":"2019","journal-title":"Nutrients"},{"issue":"3 Suppl 1","key":"10.1016\/j.diabres.2025.112235_b1080","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b1085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ndt\/gfx085","article-title":"Mediterranean diet as the diet of choice for patients with chronic kidney disease","volume":"33","author":"Chauveau","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2025.112235_b1090","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1463502","article-title":"Safety and impact of the Mediterranean diet in patients with chronic kidney disease: a pilot randomized crossover trial","volume":"11","author":"Kwon","year":"2024","journal-title":"Front Nutr"},{"issue":"20","key":"10.1016\/j.diabres.2025.112235_b1095","doi-asserted-by":"crossref","DOI":"10.3390\/nu15204444","article-title":"The Impact of Nutritional Therapy in the Management of Overweight\/Obese PCOS Patient Candidates for IVF","volume":"15","author":"Meneghini","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.diabres.2025.112235_b1100","article-title":"Effects of ketogenic diet on weight loss parameters among obese or overweight patients with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trails. Food","volume":"68","author":"Xing","year":"2024","journal-title":"Nutr Res"},{"key":"10.1016\/j.diabres.2025.112235_b1105","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1395977","article-title":"Ketogenic diet improves fertility in patients with polycystic ovary syndrome: a brief report","volume":"11","author":"Tsushima","year":"2024","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1110","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad274","article-title":"Risks of the ketogenic diet in CKD - the con part","volume":"17","author":"Joshi","year":"2024","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1115","doi-asserted-by":"crossref","DOI":"10.3390\/diseases9020039","article-title":"Incidence and characteristics of kidney stones in patients on ketogenic diet a systematic review and meta-analysis","volume":"9","author":"Acharya","year":"2021","journal-title":"Diseases"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09513590500170049","article-title":"Different routes of progesterone administration and polycystic ovary syndrome: a review of the literature","volume":"21","author":"Unfer","year":"2005","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"10.1016\/j.diabres.2025.112235_b1125","article-title":"Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives","volume":"13","author":"Santander","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b1130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b1135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041070","article-title":"Oxidative Stress Is Increased in Combined Oral Contraceptives Users and Is Positively Associated with High-Sensitivity C-Reactive Protein","volume":"26","author":"Cauci","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b1140","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s00421-021-04734-0","article-title":"Temporal changes in blood oxidative stress biomarkers across the menstrual cycle and with oral contraceptive use in active women","volume":"121","author":"Quinn","year":"2021","journal-title":"Eur J Appl Physiol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4158\/EP.14.2.193","article-title":"Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker","volume":"14","author":"Patel","year":"2008","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.diabres.2025.112235_b1150","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1055\/s-0042-1745790","article-title":"Renin-Angiotensin-Aldosterone System in Women Using Combined Oral Contraceptive: A Systematic Review","volume":"44","author":"Dos Santos","year":"2022","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b1155","doi-asserted-by":"crossref","first-page":"R807","DOI":"10.1152\/ajpregu.2001.280.3.R807","article-title":"Effect of oral contraceptives on the renin angiotensin system and renal function","volume":"280","author":"Kang","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b1160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063155","article-title":"Sex-Specific Effects of Estradiol and Progesterone in Ischemic Kidney Injury","volume":"25","author":"Andrianova","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.diabres.2025.112235_b1165","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13154354","article-title":"Understanding the Role of Sex Hormones in Cardiovascular Kidney Metabolic Syndrome: Toward Personalized Therapeutic Approaches","volume":"13","author":"Guldan","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b1170","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/art.24548","article-title":"Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB\/NZW mice","volume":"60","author":"Hughes","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tjog.2021.11.009","article-title":"Polycystic ovarian syndrome-current pharmacotherapy and clinical implications","volume":"61","author":"Rashid","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b1180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/cen.15008","article-title":"Potassium levels in women with polycystic ovary syndrome using spironolactone for long-term","volume":"100","author":"deOliveira","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1185","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12902-022-01143-y","article-title":"Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model","volume":"22","author":"Areloegbe","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"10.1016\/j.diabres.2025.112235_b1190","doi-asserted-by":"crossref","first-page":"F519","DOI":"10.1152\/ajprenal.00606.2018","article-title":"Spironolactone reduces oxidative stress in living donor kidney transplantation: a randomized controlled trial","volume":"317","author":"Morales-Buenrostro","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1016\/j.diabres.2025.112235_b1195","article-title":"Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease","volume":"10","author":"Chung","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2012.352","article-title":"Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury","volume":"83","author":"Barrera-Chimal","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1205","first-page":"687","article-title":"Effectiveness and Safety of Spironolactone in the Treatment of IgA Nephropathy: A Retrospective Self-Controlled Study","volume":"49","author":"Shang","year":"2024","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b1210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00210-019-01759-3","article-title":"Effects of single and dual RAAS blockade therapy on progressive kidney disease transition to CKD in rats","volume":"393","author":"Aggarwal","year":"2020","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13048-019-0555-8","article-title":"Effects of metformin and Exenatide on insulin resistance and AMPKalpha-SIRT1 molecular pathway in PCOS rats","volume":"12","author":"Tao","year":"2019","journal-title":"J Ovarian Res"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b1220","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","article-title":"Molecular mechanism of action of metformin: old or new insights?","volume":"56","author":"Rena","year":"2013","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b1225","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1230","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1210\/clinem\/dgad465","article-title":"Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis","volume":"109","author":"Melin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b1235","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/acsptsci.1c00167","article-title":"Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?","volume":"4","author":"Ala","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbadis.2017.10.014","article-title":"Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK","volume":"1864","author":"Rogacka","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9","key":"10.1016\/j.diabres.2025.112235_b1245","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1002\/jcp.26505","article-title":"Metformin attenuates folic-acid induced renal fibrosis in mice","volume":"233","author":"Yi","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.diabres.2025.112235_b1250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2015.01.042","article-title":"Activation of AMPK by metformin inhibits TGF-beta-induced collagen production in mouse renal fibroblasts","volume":"127","author":"Lu","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.diabres.2025.112235_b1255","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.603802","article-title":"Metformin Attenuates Renal Fibrosis in a Mouse Model of Adenine-Induced Renal Injury Through Inhibiting TGF-beta1 Signaling Pathways","volume":"9","author":"Yi","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020146","article-title":"Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts","volume":"17","author":"Shen","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.diabres.2025.112235_b1265","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14141","article-title":"Metformin modulates immune cell infiltration into the kidney during unilateral ureteral obstruction in mice","volume":"7","author":"Christensen","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1016\/j.diabres.2025.112235_b1270","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2147\/DDDT.S409373","article-title":"Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes","volume":"17","author":"Dutta","year":"2023","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"10.1016\/j.diabres.2025.112235_b1275","doi-asserted-by":"crossref","first-page":"E1645","DOI":"10.1210\/jc.2011-1093","article-title":"Metformin and\/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome","volume":"96","author":"Aubuchon","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","article-title":"Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Greff","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09513590.2016.1236078","article-title":"Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)","volume":"33","author":"Fruzzetti","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b1290","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tem.2020.02.002","article-title":"Inositols in Polycystic Ovary Syndrome: An Overview on the Advances","volume":"31","author":"Facchinetti","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112235_b1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153653","article-title":"Role of myo-inositol in acute kidney injury induced by cisplatin","volume":"499","author":"Xie","year":"2023","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1300","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010016","article-title":"Myo-Inositol Supplementation Alleviates Cisplatin-Induced Acute Kidney Injury via Inhibition of Ferroptosis","volume":"12","author":"Qi","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1305","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1038\/s41598-019-51276-9","article-title":"Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis","volume":"9","author":"An","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b1310","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13041056","article-title":"The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: A Review","volume":"13","author":"Porth","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b1315","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/cen.13968","article-title":"Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study","volume":"90","author":"Javed","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","article-title":"Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition","volume":"60","author":"Vallon","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112235_b1325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1213473","article-title":"Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease","volume":"14","author":"Dai","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2025.112235_b1330","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112235_b1335","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/kidneydial2020032","article-title":"The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1","volume":"2","author":"Oe","year":"2022","journal-title":"Kidney Dial"},{"key":"10.1016\/j.diabres.2025.112235_b1340","article-title":"FDA Approves Semaglutide to Reduce Risk of Kidney Disease Progression","author":"Anderer","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2025.112235_b1345","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/DDDT.S484531","article-title":"Semaglutide Alleviates Ovary Inflammation via the AMPK\/SIRT1\/NF\u2011kappaB Signaling Pathway in Polycystic Ovary Syndrome Mice","volume":"18","author":"Liu","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.diabres.2025.112235_b1350","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/DMSO.S451129","article-title":"Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention","volume":"17","author":"Xiong","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b1355","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/MS9.0000000000003126","article-title":"A meta-analytic review of the safety and efficacy of semaglutide in type 2 diabetes mellitus and chronic kidney disease patients","volume":"87","author":"Ashraf","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.diabres.2025.112235_b1360","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2147\/DMSO.S498447","article-title":"Protective Effect of Semaglutide on Obesity-Induced Renal Disease and Obesity-Induced Kidney Renal Clear Cell Carcinoma","volume":"18","author":"Wang","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"18","key":"10.1016\/j.diabres.2025.112235_b1365","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185915","article-title":"Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies","volume":"12","author":"Szczesnowicz","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.diabres.2025.112235_b1370","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.metabol.2012.03.002","article-title":"GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases","volume":"61","author":"Hendarto","year":"2012","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b1375","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4239\/wjd.v4.i5.190","article-title":"Effects of glucagon-like peptide-1 receptor agonists on renal function","volume":"4","author":"Filippatos","year":"2013","journal-title":"World J Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b1380","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b1385","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","article-title":"Dyslipidemia involvement in the development of polycystic ovary syndrome","volume":"58","author":"Liu","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"5519","key":"10.1016\/j.diabres.2025.112235_b1390","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.diabres.2025.112235_b1395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1400","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1405","article-title":"Effect of atorvastatin on testosterone levels","volume":"1","author":"Shawish","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.diabres.2025.112235_b1410","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2007.11.003","article-title":"Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization","volume":"198","author":"Naples","year":"2008","journal-title":"Atherosclerosis"},{"issue":"13","key":"10.1016\/j.diabres.2025.112235_b1415","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/00003495-200868130-00001","article-title":"HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?","volume":"68","author":"Kodaman","year":"2008","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.diabres.2025.112235_b1420","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.12669\/pjms.37.5.4045","article-title":"Atorvastatin calcium tablets on inflammatory factors, hemorheology and renal function damage indexes in patients with diabetic nephropathy","volume":"37","author":"Li","year":"2021","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.diabres.2025.112235_b1425","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2147\/CLEP.S360395","article-title":"The Association Between Statin Use and Risk of Chronic Kidney Disease in Community-Dwelling Older People in Shanghai","volume":"14","author":"Zhao","year":"2022","journal-title":"China Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.diabres.2025.112235_b1430","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1053\/j.ajkd.2016.01.016","article-title":"Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis","volume":"67","author":"Su","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.diabres.2025.112235_b1435","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amjcard.2015.11.031","article-title":"Statin Use and the Risk of Kidney Disease With Long-Term Follow-Up (8.4-Year Study)","volume":"117","author":"Acharya","year":"2016","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.diabres.2025.112235_b1440","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/eurheartj\/ehad640","article-title":"Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial","volume":"45","author":"Wijesurendra","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725002499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725002499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:48:53Z","timestamp":1778388533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725002499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":288,"alternative-id":["S0168822725002499"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112235","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112235"}}